Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577742
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-10-03
Brief Title:
Uveal Melanoma and Brachytheraphy Long-term Outcomes
Sponsor:
Federico II University
Organization:
Federico II University
Study Overview
Official Title:
Long-term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study investigated the visual and anatomical outcomes tumor control tumor recurrence distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None